Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adrenocortical Carcinoma × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Carcinoma, Non-Small-Cell Lung 35 Ovarian Neoplasms 34 Stomach Neoplasms 30 Esophageal Neoplasms 24 Esophageal Squamous Cell Carcinoma 17 Fallopian Tube Neoplasms 16 Uterine Cervical Neoplasms 15 Carcinoma, Ovarian Epithelial 13 Lung Neoplasms 12 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Neoplasms 8 Carcinoma, Squamous Cell 8 Recurrence 6 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Nasopharyngeal Neoplasms 5 Advanced Gastric Cancer 5 Pancreatic Neoplasms 4 Hypopharyngeal Neoplasms 4 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Carcinoma 3 Anus Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumors 2

Interventions

cabazitaxel 1 Sorafenib 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Mitotane 1 Lymph Node Excision 1 Indinavir 1 IPI-549 1 Blood Specimen Collection 1 Adrenalectomy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786110 2009-02-24

PAXO

University of Turin, Italy

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡